江中药业2025年归母净利润同比增长14.96%

Core Viewpoint - Jiangzhong Pharmaceutical reported a decrease in revenue for 2025, while net profit showed significant growth, indicating a mixed performance in financial results [1] Financial Performance - The company achieved an operating income of 4.22 billion yuan in 2025, a year-on-year decrease of 4.87% [1] - The net profit attributable to shareholders of the listed company was 906 million yuan, reflecting a year-on-year increase of 14.96% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 832 million yuan, which represents a year-on-year growth of 11.1% [1]